Our product sourcing, testing and quality standards

At Peptidology, quality isn't a marketing claim — it's an engineering discipline. Every batch we sell undergoes our 14x analytical testing protocol, the most rigorous quality program in the research chemical industry. This page explains exactly what we do, why we do it, and how it protects you.

We source raw materials exclusively from FDA-audited, registered, and inspected facilities manufacturing under stringent cGMP guidelines. Our current supplier network includes facilities in the United States, Taiwan, and Hong Kong.

Rather than limiting ourselves to a single country of origin, we intentionally diversify our supply chain. This approach allows us to mitigate risks from regulatory changes, price volatility, and availability disruptions — all without compromising quality. We evaluate every supplier based on compliance records, audit history, and analytical data, not geography alone.

We actively monitor our suppliers' FDA inspection records for any compliance issues documented on Form FDA 483 observations or warning letters. Since we began operations, none of our suppliers have received adverse findings.

The industry standard for research chemical testing is 2–3 basic tests per batch. We perform 14 distinct analytical tests across two independent, FDA-audited U.S. laboratories — Vanguard Laboratory (Olympia, WA) and Eagle Analytical Services (Houston, TX). Every batch must clear the full panel before a single vial ships.

We test up to 28 finished-product vials per batch, pulled at random. Here is exactly what we test for and why:

Measures overall peptide purity using high-performance liquid chromatography. Our finished products must exceed >99% purity. Raw materials are held to an even tighter standard of >99.5%. This confirms the product is what it claims to be, with minimal degradation or impurities. Tested across 3 vials per batch.

Each active peptide in a product is independently assayed to verify the labeled dose is accurate. For combination products, every peptide is measured separately — for example, both CJC-1295 and Ipamorelin are individually quantified across 3 vials. This ensures you receive the exact amount stated on the label.

We screen for five elemental impurities using inductively coupled plasma mass spectrometry, one of the most sensitive detection methods available, and evaluate results against USP <232> Elemental Impurities acceptance criteria:

All results must fall within the acceptance limits established by USP <232>. Most competitors in the research chemical space either skip this panel entirely or test for fewer metals with less sensitive methods.

Endotoxins are toxic byproducts from bacterial cell walls that can cause fever, inflammation, and serious adverse reactions. We test 2 vials per batch using the LAL (Limulus Amebocyte Lysate) method against the USP/FDA threshold of <5 EU/kg (350 EU total for a 70 kg adult). Every vial must pass.

The gold-standard compendial sterility test. Five vials per batch are incubated and observed for microbial growth per USP <71> methodology. Every vial must return "Pass — No Growth." This is a 14-day incubation protocol — we don't cut corners with shorter methods.

In addition to the USP <71> test at Vanguard, we send up to 15 separate vials per batch to Eagle Analytical Services in Houston for independent rapid sterility confirmation using the ScanRDI method. This gives us double sterility verification from two independent labs using two different methodologies, with up to 20 total vials tested for sterility alone — a level of redundancy virtually unheard of in this industry.

Peptide synthesis involves chemical solvents that must be fully removed from the final product. We screen for 16 individual residual solvents using gas chromatography-mass spectrometry, including:

All 16 solvents must return as Non-Detect. This test is rarely performed by research chemical companies due to its cost and complexity.

A sterile product is only sterile if the container seal holds. We test 2 vials per batch using the dye ingress method to confirm that no external contaminants can enter the vial after it has been sealed. This verifies that the crimp seal, stopper, and glass vial form an airtight barrier throughout the product's shelf life.

Each lyophilized (freeze-dried) peptide must fully reconstitute when bacteriostatic water is added. We verify that 2 vials per batch achieve full solubility in 2 mL of water with no visible particulates, clumping, or incomplete dissolution. If it doesn't dissolve cleanly, the batch doesn't ship.

TFA is a common counterion used during peptide synthesis. Residual TFA at high levels can cause irritation and other adverse effects. We test to confirm TFA content is Non-Detect at <0.10% using ion chromatography.

Why 14x matters: Most research chemical companies perform 2–3 tests and call it a day. Our 14x protocol means every batch is tested for purity, potency, sterility (twice, at two labs), endotoxins, heavy metals, residual solvents, container integrity, solubility, and residual process chemicals. If any single test fails, the entire batch is rejected.

All testing is performed by two independent, U.S.-based, FDA-audited analytical laboratories:

Vanguard Laboratory — Olympia, WA
ISO/IEC 17025:2017 accredited (A2LA Certificate #6377.01.01). Performs the full analytical panel including purity, assay, heavy metals, endotoxins, sterility, residual solvents, container closure integrity, solubility, and TFA analysis.

Eagle Analytical Services — Houston, TX
Provides independent sterility confirmation via the ScanRDI rapid sterility method, serving as our second-lab verification to ensure no single point of failure in sterility testing.

By splitting testing across two laboratories, we eliminate the risk of a single lab's error going undetected. If Lab A says it's sterile but Lab B disagrees, the batch is rejected. Period.

Our monthly analytical testing spend ranges from $30,000 to $50,000, not including the cost of destroyed product samples or the dedicated staff required to manage our testing pipeline. This represents roughly 450% more than what competitors spend on quality testing.

Testing also adds significant lead time. Our full 14x protocol requires up to 45 days to complete — compared to the 2-day turnaround most companies accept. We believe the wait is worth it.

Our finished products are manufactured in GMP-aligned facilities in the United States, Taiwan, and China using aseptic processing. All products pass through a 0.22 µm sterile PES membrane filter before lyophilization (freeze-drying) to ensure sterility at the point of fill.

Every finished product vial receives a unique batch-coded QR code that links directly to the Certificate of Analysis for that specific batch, including test results and expiration dates. You can verify any product you receive in seconds.

We built the 14x protocol because we believe you deserve confidence in every vial. It's slower, it's expensive, and it means we reject batches our competitors would happily sell. That's exactly the point.

Every Certificate of Analysis is available via the QR code on your product. If you ever have a question about a specific batch, reach out to our team and we'll walk you through the results.